Brown, Lisle/Cummings’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
7,006
+340
| +5% | +$138K | 0.76% | 36 |
|
|
2025
Q1 | $3.32M | Sell |
6,666
-2
| -0% | -$995 | 0.96% | 25 |
|
|
2024
Q4 | $3.47M | Sell |
6,668
-59
| -0.9% | -$30.7K | 1.04% | 23 |
|
|
2024
Q3 | $4.16M | Buy |
6,727
+300
| +5% | +$186K | 1.26% | 17 |
|
|
2024
Q2 | $3.55M | Buy |
6,427
+15
| +0.2% | +$8.3K | 1.16% | 21 |
|
|
2024
Q1 | $3.73M | Buy |
6,412
+360
| +6% | +$209K | 1.27% | 21 |
|
|
2023
Q4 | $3.21M | Buy |
6,052
+175
| +3% | +$92.9K | 1.19% | 21 |
|
|
2023
Q3 | $2.97M | Buy |
5,877
+144
| +3% | +$72.9K | 1.35% | 20 |
|
|
2023
Q2 | $2.99M | Buy |
5,733
+235
| +4% | +$123K | 1.34% | 18 |
|
|
2023
Q1 | $3.17M | Sell |
5,498
-50
| -0.9% | -$28.8K | 1.61% | 13 |
|
|
2022
Q4 | $3.06M | Buy |
5,548
+261
| +5% | +$144K | 1.64% | 12 |
|
|
2022
Q3 | $2.68M | Sell |
5,287
-35
| -0.7% | -$17.8K | 1.57% | 14 |
|
|
2022
Q2 | $2.89M | Sell |
5,322
-140
| -3% | -$76.1K | 1.6% | 14 |
|
|
2022
Q1 | $3.23M | Buy |
5,462
+130
| +2% | +$76.8K | 1.55% | 14 |
|
|
2021
Q4 | $3.56M | Buy |
+5,332
| New | +$3.56M | 1.78% | 12 |
|